Cyagen Biosciences
KG Huo, PhD is a Principal Scientist at Cyagen since June 2022. Prior to that, KG was a Medical Advisor at Berry Genomics from December 2021 to June 2022. KG's previous role was as a Postdoctoral Researcher at University Health Network from January 2018 to November 2021, focusing on novel therapeutics in lung cancer and performing various research and data analysis tasks. KG holds a PhD in Experimental Medicine from McGill University and a Bachelor of Science in Biology from Concordia University.
This person is not in any offices
Cyagen Biosciences
Cyagen specializes in generating knockout/transgenic mice, rats and cell line models, as well as virus packaging, vector cloning, stem cells and cell culture reagents.